Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer

Yu-Guo Yuan,1 Qiu-Ling Peng,2 Sangiliyandi Gurunathan3 1College of Veterinary Medicine/Animal Science and Technology/Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, 2College of Chemistry and Bioengineering,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yuan YG, Peng QL, Gurunathan S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	Tubastatin A palladium nanoparticles cell viability oxidative stress mitochondrial membrane potential caspases apoptosis Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/207075f3ce0f49119d56e28ea053289e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:207075f3ce0f49119d56e28ea053289e
record_format	dspace
spelling	oai:doaj.org-article:207075f3ce0f49119d56e28ea053289e2021-12-02T01:50:41ZCombination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer1178-2013https://doaj.org/article/207075f3ce0f49119d56e28ea053289e2017-09-01T00:00:00Zhttps://www.dovepress.com/combination-of-palladium-nanoparticles-and-tubastatin-a-potentiates-ap-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yu-Guo Yuan,1 Qiu-Ling Peng,2 Sangiliyandi Gurunathan3 1College of Veterinary Medicine/Animal Science and Technology/Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, 2College of Chemistry and Bioengineering, Yichun University, Yichun, People’s Republic of China; 3Department of Stem cell and Regenerative Biotechnology, Konkuk University, Seoul, Republic of Korea Background: Breast cancer is the most common malignant disease that occurs in women. Histone deacetylase (HDAC) inhibition has recently emerged as an effective and attractive target for the treatment of cancer. The aim of this study was to investigate the efficacy of a combined treatment of tubastatin A (TUB-A) and palladium nanoparticles (PdNPs) against MDA-MB-231 human breast cancer cells using two different cytotoxic agents that work by two different mechanisms, thereby decreasing the probability of chemoresistance in cancer cells and increasing the efficacy of toxicity, to provide efficient therapy for advanced stage of cancer without any undesired side effects. Methods: PdNPs were synthesized using a novel biomolecule called R-phycoerythrin and characterized using various analytical techniques. The combinatorial effect of TUB-A and PdNPs was assessed by various cellular and biochemical assays and also by gene expression analysis. Results: The biologically synthesized PdNPs had an average size of 25 nm and were spherical in shape. Treatment of MDA-MB-231 human breast cancer cells with TUB-A or PdNPs showed a dose-dependent effect on cell viability. The combination of 4 µM TUB-A and 4 µM PdNPs had a significant inhibitory effect on cell viability compared with either TUB-A or PdNPs alone. The combinatorial treatment also had a more pronounced effect on the inhibition of HDAC activity and enhanced apoptosis by regulating various cellular and biochemical changes. Conclusion: Our results suggest that there was a strong synergistic interaction between TUB-A and PdNPs in increasing apoptosis in human breast cancer cells. These data provide an important preclinical basis for future clinical trials on this drug combination. This combinatorial treatment increased therapeutic potentials, thereby demonstrating a relevant targeted therapy for breast cancer. Furthermore, we have provided the first evidence for the combinatorial effect and mechanism of toxicity of TUB-A and PdNPs in human breast cancer cells. The novelties of the study were identification of a combination therapy that consists of suitable therapeutic molecules that kill cancer cells and also exploration of two different possible mechanisms involved to reduce chemoresistance in cancer cells. Keywords: tubastatin A, palladium nanoparticles, cell viability, oxidative stress, mitochondrial membrane potential, caspases, apoptosisYuan YGPeng QLGurunathan SDove Medical PressarticleTubastatin Apalladium nanoparticlescell viabilityoxidative stressmitochondrial membrane potentialcaspasesapoptosisMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 6503-6520 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Tubastatin A palladium nanoparticles cell viability oxidative stress mitochondrial membrane potential caspases apoptosis Medicine (General) R5-920
spellingShingle	Tubastatin A palladium nanoparticles cell viability oxidative stress mitochondrial membrane potential caspases apoptosis Medicine (General) R5-920 Yuan YG Peng QL Gurunathan S Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
description	Yu-Guo Yuan,1 Qiu-Ling Peng,2 Sangiliyandi Gurunathan3 1College of Veterinary Medicine/Animal Science and Technology/Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, 2College of Chemistry and Bioengineering, Yichun University, Yichun, People’s Republic of China; 3Department of Stem cell and Regenerative Biotechnology, Konkuk University, Seoul, Republic of Korea Background: Breast cancer is the most common malignant disease that occurs in women. Histone deacetylase (HDAC) inhibition has recently emerged as an effective and attractive target for the treatment of cancer. The aim of this study was to investigate the efficacy of a combined treatment of tubastatin A (TUB-A) and palladium nanoparticles (PdNPs) against MDA-MB-231 human breast cancer cells using two different cytotoxic agents that work by two different mechanisms, thereby decreasing the probability of chemoresistance in cancer cells and increasing the efficacy of toxicity, to provide efficient therapy for advanced stage of cancer without any undesired side effects. Methods: PdNPs were synthesized using a novel biomolecule called R-phycoerythrin and characterized using various analytical techniques. The combinatorial effect of TUB-A and PdNPs was assessed by various cellular and biochemical assays and also by gene expression analysis. Results: The biologically synthesized PdNPs had an average size of 25 nm and were spherical in shape. Treatment of MDA-MB-231 human breast cancer cells with TUB-A or PdNPs showed a dose-dependent effect on cell viability. The combination of 4 µM TUB-A and 4 µM PdNPs had a significant inhibitory effect on cell viability compared with either TUB-A or PdNPs alone. The combinatorial treatment also had a more pronounced effect on the inhibition of HDAC activity and enhanced apoptosis by regulating various cellular and biochemical changes. Conclusion: Our results suggest that there was a strong synergistic interaction between TUB-A and PdNPs in increasing apoptosis in human breast cancer cells. These data provide an important preclinical basis for future clinical trials on this drug combination. This combinatorial treatment increased therapeutic potentials, thereby demonstrating a relevant targeted therapy for breast cancer. Furthermore, we have provided the first evidence for the combinatorial effect and mechanism of toxicity of TUB-A and PdNPs in human breast cancer cells. The novelties of the study were identification of a combination therapy that consists of suitable therapeutic molecules that kill cancer cells and also exploration of two different possible mechanisms involved to reduce chemoresistance in cancer cells. Keywords: tubastatin A, palladium nanoparticles, cell viability, oxidative stress, mitochondrial membrane potential, caspases, apoptosis
format	article
author	Yuan YG Peng QL Gurunathan S
author_facet	Yuan YG Peng QL Gurunathan S
author_sort	Yuan YG
title	Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
title_short	Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
title_full	Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
title_fullStr	Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
title_full_unstemmed	Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
title_sort	combination of palladium nanoparticles and tubastatin-a potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/207075f3ce0f49119d56e28ea053289e
work_keys_str_mv	AT yuanyg combinationofpalladiumnanoparticlesandtubastatinapotentiatesapoptosisinhumanbreastcancercellsanoveltherapeuticapproachforcancer AT pengql combinationofpalladiumnanoparticlesandtubastatinapotentiatesapoptosisinhumanbreastcancercellsanoveltherapeuticapproachforcancer AT gurunathans combinationofpalladiumnanoparticlesandtubastatinapotentiatesapoptosisinhumanbreastcancercellsanoveltherapeuticapproachforcancer
_version_	1718402819741974528

Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer

Ejemplares similares